Serum myeloperoxidase and adenosine deaminase activities in polycystic ovary syndrome

References

• Asunción M , Calvo RM , San Millán JL , Sancho J , Avila S , Escobar-Morreale HF . A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–2438.
   PubMed Web of Science ®Google Scholar
• Azziz R , Woods KS , Reyna R , Key TJ , Knochenhauer ES , Yildiz BO . The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–2749.
   PubMed Web of Science ®Google Scholar
• Ruan X , Dai Y . Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome. Med Princ Pract 2009;18:118–122.
   PubMed Web of Science ®Google Scholar
• Orio F Jr , Palomba S , Cascella T , Di Biase S , Manguso F , Tauchmanova L , Nardo LG , et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:2–5.
   PubMed Web of Science ®Google Scholar
• Amato G , Conte M , Mazziotti G , Lalli E , Vitolo G , Tucker AT , Bellastella A , et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 2003;101:1177–1182.
   PubMed Web of Science ®Google Scholar
• Kilic S , Yilmaz N , Zulfikaroglu E , Erdogan G , Aydin M , Batioglu S. Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment. Gynecol Endocrinol 2010, doi:10.3109/09513590.2010.530706. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Mohamadin AM , Habib FA , Al-Saggaf AA . Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine. Ann Saudi Med 2010;30:278–283.
   PubMed Web of Science ®Google Scholar
• Repaci A , Gambineri A , Pasquali R . The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2011;335:30–41.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V , Rieu P , Descamps-Latscha B , Lesavre P , Halbwachs-Mecarelli L . Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617–653.
   PubMed Web of Science ®Google Scholar
• Zhang R , Brennan ML , Fu X , Aviles RJ , Pearce GL , Penn MS , Topol EJ , et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001;286:2136–2142.
   PubMed Web of Science ®Google Scholar
• Meuwese MC , Stroes ES , Hazen SL , van Miert JN , Kuivenhoven JA , Schaub RG , Wareham NJ , et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159–165.
   PubMed Web of Science ®Google Scholar
• Podrez EA , Abu-Soud HM , Hazen SL . Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000;28:1717–1725.
   PubMed Web of Science ®Google Scholar
• Pallinti V , Ganesan N , Anbazhagan M , Rajasekhar G . Serum biochemical markers in rheumatoid arthritis. Indian J Biochem Biophys 2009;46:342–344.
   PubMed Web of Science ®Google Scholar
• Kisacik B , Akdogan A , Yilmaz G , Karadag O , Yilmaz FM , Koklu S , Yuksel O , et al. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever. Eur J Intern Med 2009;20:44–47.
   PubMed Web of Science ®Google Scholar
• Albera C , Mabritto I , Ghio P , Solidoro P , Marchetti L , Pozzi E . Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis. Sarcoidosis 1993;10:18–25.
   PubMedGoogle Scholar
• Chavan V , Patil N , Karnik ND . Study of leukocytic hydrolytic enzymes in patients with acute stage of coronary heart disease. Indian J Med Sci 2007;61:73–82.
   PubMedGoogle Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Li X , Lin JF . [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Zhonghua Yi Xue Za Zhi 2005;85:3266–3271.
   PubMedGoogle Scholar
• Giusti G. Adenosine deaminase. In: Bergmeyer HU , editor. Methods of enzymatic analysis. New York: Academic Press; 1974. pp 1092–1099.
   Google Scholar
• Bradley PP , Priebat DA , Christensen RD , Rothstein G . Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206–209.
   PubMed Web of Science ®Google Scholar
• Cho LW , Kilpatrick ES , Jayagopal V , Diver MJ , Atkin SL . Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia. Clin Endocrinol (Oxf) 2008;68:390–394.
   PubMed Web of Science ®Google Scholar
• Amato MC , Verghi M , Nucera M , Galluzzo A , Giordano C . Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. Gynecol Endocrinol 2010 (in press). [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Bukulmez O , Arici A . Leukocytes in ovarian function. Hum Reprod Update 2000;6:1–15.
   PubMed Web of Science ®Google Scholar
• Kelly CC , Lyall H , Petrie JR , Gould GW , Connell JM , Sattar N . Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001;86:2453–2455.
   PubMed Web of Science ®Google Scholar
• Wu R , Fujii S , Ryan NK , Van der Hoek KH , Jasper MJ , Sini I , Robertson SA , et al. Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome. Hum Reprod 2007;22:527–535.
   PubMed Web of Science ®Google Scholar
• Ibáñez L , Jaramillo AM , Ferrer A , de Zegher F . High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception. Hum Reprod 2005;20:2457–2462.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF , Botella-Carretero JI , Villuendas G , Sancho J , San Millán JL . Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 2004;89:806–811.
   PubMed Web of Science ®Google Scholar
• Gonzalez F , Thusu K , Abdel-Rahman E , Prabhala A , Tomani M , Dandona P . Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metab Clin Exp 1999;48:437–441.
   PubMed Web of Science ®Google Scholar
• Zhang YF , Yang YS , Hong J , Gu WQ , Shen CF , Xu M , Du PF , et al. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 2006;29:419–423.
   PubMed Web of Science ®Google Scholar
• Benson S , Janssen OE , Hahn S , Tan S , Dietz T , Mann K , Pleger K , et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun 2008;22:177–184.
   PubMed Web of Science ®Google Scholar
• Karaer A , Cavkaytar S , Mert I , Buyukkagnici U , Batioglu S . Cardiovascular risk factors in polycystic ovary syndrome. J Obstet Gynaecol 2010;30:387–392.
   PubMedGoogle Scholar
• Shroff R , Kerchner A , Maifeld M , Van Beek EJ , Jagasia D , Dokras A . Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 2007;92:4609–4614.
   PubMed Web of Science ®Google Scholar
• Bickerton AS , Clark N , Meeking D , Shaw KM , Crook M , Lumb P , Turner C , Cummings MH . Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol 2005;58:151–154.
   PubMed Web of Science ®Google Scholar
• Samy N , Hashim M , Sayed M , Said M . Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009;26:163–170.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF , Luque-Ramirez M , Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011;95:1048-58.e1-2.
   Web of Science ®Google Scholar
• Sasıkala SL , Shamıla S , Nagarajan S , Nısha JC , Geetha P , Kıshor Raj S. A comparative study of Ashokarishtam and clomiphere citrate in combating polycystic ovary syndrome induced oxidative stress in rat. J Cell Tissue Res 2010;10:2105–2108.
   Google Scholar
• Dursun E , Akalin FA , Güncü GN , Çinar N , Aksoy DY , Tözüm TF , Kilinc K , Yildiz BO . Periodontal disease in polycystic ovary syndrome. Fertil Steril 2011;95:320–323.
   PubMedGoogle Scholar
• Heslop CL , Frohlich JJ , Hill JS . Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010;55:1102–1109.
   PubMed Web of Science ®Google Scholar